Form 4: MicroVision Executive Vesting 22,007 Shares

MicroVision's Executive Vice Chair, Simon Biddiscombe, vested 22,007 restricted stock units into common stock, correcting a prior filing error.

Summary

• Simon Biddiscombe, Executive Vice Chair and Director of MicroVision, Inc., acquired 22,007 shares of common stock through the vesting of restricted stock units (RSUs).
• The transaction occurred on March 2, 2026, with a conversion price of $0.00 per share.
• Following this transaction, Mr. Biddiscombe directly beneficially owns 291,299 shares of MicroVision common stock.
• The filing also corrects an error from a previous Form 4 filed on June 6, 2025, which misreported the total RSUs granted on June 5, 2025, as 87,462 instead of the correct amount of 88,028 RSUs. The current vesting calculation is based on the corrected RSU amount.
• The RSUs were granted on June 6, 2025, and are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, contingent on continued service.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a slightly positive event, as it represents a routine vesting of executive compensation and a transparent correction of a prior administrative error, indicating standard corporate operations and governance.

Positives

• Executive Vice Chair Simon Biddiscombe increased his direct beneficial ownership of MicroVision common stock by 22,007 shares through RSU vesting, demonstrating continued alignment with shareholder interests.
• The company is transparent in correcting a previous administrative error regarding the total number of RSUs granted.

Negatives

• The transaction represents a scheduled vesting of previously granted compensation, not a new open-market purchase of shares by the executive.

Future Outlook

The RSUs granted on June 6, 2025, are scheduled to continue vesting in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, contingent on the reporting person's continued service as a director.

Industry Context

StockSavvy.ai notes that routine insider filings like Form 4, especially for RSU vesting, are common across all industries as part of executive compensation packages. This particular filing does not provide broader industry insights but confirms ongoing executive compensation practices at MicroVision.

Stakeholder Impact

• Shareholders: The increase in direct beneficial ownership by an executive may be viewed positively as it aligns management's interests with shareholders. The correction of a prior filing error enhances transparency.
• Employees: The vesting of RSUs is a standard component of executive compensation, reflecting ongoing employee incentive programs.

Next Steps

• Remaining tranches of RSUs granted on June 6, 2025, are scheduled to vest in equal quarterly installments.
• Full vesting of the RSUs is expected on the earlier of the first anniversary of the grant date (June 6, 2026) or the day prior to MicroVision's 2026 Annual Meeting of Stockholders, subject to continued service.

Key Dates

Recommendation

This Form 4 filing details a routine vesting of restricted stock units for an executive and corrects a minor administrative error in a previous filing. It does not contain information significant enough to warrant a change in investment recommendation. The transaction is an expected part of executive compensation and does not reflect new operational performance or strategic shifts. Therefore, a "hold" recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

MicroVision, MVIS, Form 4, SEC Filing, Insider Transaction, Restricted Stock Units, RSU Vesting, Simon Biddiscombe, Executive Compensation, Share Ownership